Bailard’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-146,752
| Closed | -$907K | – | 444 |
|
|
2017
Q3 | $907K | Hold |
146,752
| – | – | 0.07% | 173 |
|
|
2017
Q2 | $1.36M | Hold |
146,752
| – | – | 0.11% | 156 |
|
|
2017
Q1 | $1.36M | Sell |
146,752
-100,000
| -41% | -$928K | 0.11% | 156 |
|
|
2016
Q4 | $2.07M | Sell |
246,752
-68,000
| -22% | -$569K | 0.19% | 122 |
|
|
2016
Q3 | $2.16M | Buy |
314,752
+95,000
| +43% | +$653K | 0.2% | 114 |
|
|
2016
Q2 | $1.09M | Hold |
219,752
| – | – | 0.13% | 154 |
|
|
2016
Q1 | $2.12M | Buy |
+219,752
| New | +$2.12M | 0.3% | 62 |
|
|
2015
Q4 | – | Sell |
-92,000
| Closed | -$1.29M | – | 295 |
|
|
2015
Q3 | $1.29M | Buy |
92,000
+37,000
| +67% | +$520K | 0.2% | 78 |
|
|
2015
Q2 | $1.16M | Hold |
55,000
| – | – | 0.18% | 94 |
|
|
2015
Q1 | $2.31M | Buy |
+55,000
| New | +$2.31M | 0.32% | 53 |
|